Niki BioSolutions annual gross margin
2021
2022
2023
Niki BioSolutions's gross margin was 2.45% for fiscal 2023.
View full Niki BioSolutions company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2023 | 2023-12-31 | 2.45% | −3.73 pp |
| 2022 | 2022-12-31 | 6.18% | +0.87 pp |
| 2021 | 2021-12-31 | 5.31% | — |
Between the periods ended 2021-12-31 and 2023-12-31, Niki BioSolutions's gross margin decreased from 5.31% to 2.45%, a change of −2.86 percentage points.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Niki BioSolutions source filings ↗